During the past decade, Qualiclinic Kft. conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 26 clinical trials were completed, i.e. on average, 96.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 14 clinical trials were completed. i.e. 127.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Qualiclinic Kft." #1 sponsor was "Pfizer" with 15 trials, followed by "Amgen" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Qualiclinic Kft." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Qualiclinic Kft." are "Rheumatoid Arthritis" (11 trials), "Psoriatic Arthritis" (6 trials), "Systemic Lupus Erythematosus" (5 trials), "Arthritis, Psoriatic" (3 trials) and "Lupus Erythematosus, Systemic" (2 trials). Many other conditions were trialed in "Qualiclinic Kft." in a lesser frequency.

Most popular intervention types in "Qualiclinic Kft." are "Drug" (30 trials), "Biological" (7 trials), "Other" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Adalimumab" (2 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Qualiclinic Kft." are 36 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Qualiclinic Kft.". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Qualiclinic Kft., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Qualiclinic Kft., 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".